Found 34 matching trials
Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B Patients PHASE4 The current study is a prospective, randomized, open, multi-center investig...
Show More Location
Xixi Hospital of Hangzhou
Learn More & Join Trial
REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B Infection PHASE2 NAPs have been previously shown to clear serum hepatitis B virus surface an...
Show More Location
Infectious Clinical Hospital (n.a. Toma Ciorba) Department 5
Learn More & Join Trial
Addition of PegIFN Alfa-2a to CHB Patients Treated With Nucleot(s)Ides PHASE4 This study evaluates whether PegIFN alfa-2a add on can improve CHB patients...
Show More Location
Multiple Locations
Learn More & Join Trial
Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B PHASE3 This clinical trial compares the efficacy of peginterferon plus tenofovir f...
Show More Location
Cedars Sinai Medical Center
Learn More & Join Trial
HEllenic Multicenter ReAl-life CLInical Study for Bulevirtide Therapy in Chronic Hepatitis D: HERACLIS-BLV N/A This study aims to assess the efficacy and safety of bulevirtide (BLV) in c...
Show More Location
Department of Gastroenterology, Medical School of National & Kapodistrian University of Athens, General Hospital of Athens "Laiko";
Learn More & Join Trial
Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients PHASE3 The efficacy of pegylated interferons in the treatment of chronic hepatitis...
Show More Location
ifi Institut für Interdisziplinäre Medizin
Learn More & Join Trial
Phase 1b/2a Study of ABI-H0731 in Patients With Chronic Hepatitis B PHASE1 The purpose of this protocol is to obtain pharmacodynamic and pharmacokinet...
Show More Location
Monash University
Learn More & Join Trial
HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis PHASE2 Randomized, double blind study comparing the efficacy of pegylated interfer...
Show More Location
Charité Campus Virchow-Klinikum, Med. Klinik für Gastroenterologie und Hepatologie
Learn More & Join Trial
The Investigation of Peginterferon Alfa-2a on Optimal in Chronic Hepatitis B Patients Who Have a High Risk of HCC PHASE4 The CHB subjects who are cirrhosis, will be randomized to two groups.
The ...
Show More Learn More & Join Trial
A Study of Early Immunologic Response in Asian Patients With Chronic Hepatitis B, Treated With Pegasys (Peginterferon Alfa-2a (40KD)), Nucleoside Analogues, or Both PHASE1 This open-label, randomized, parallel-arm study will assess the early immun...
Show More Location
Multiple Locations
Learn More & Join Trial